Please Wait
Applying Filters...
menu
    • menu
    Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Arnica Montana

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    01/01/2026 Herbamed AG
    Germany
    		 Herbamed AG 64743-415 Arnica montana 30C, Euphorbium officinarum 30C, Pulsatilla 30C, Solanum nigrum 9C 2024-04-10 2026-12-31 DRUG FOR FURTHER PROCESSING POWDER (30kg 30kg 30kg 9kg)
    01/01/2026 Schmidt Nagel Laboratory
    Switzerland
    		 Laboratoire Schmidt-Nagel 73296-031 Arnica Montana, Rhus Toxicodendron, Ledum Palustre, Calendula Officinalis, Ruta Graveolens 2016-03-25 2026-12-31 DRUG FOR FURTHER PROCESSING POWDER (3012kg 612kg 612kg 612kg 1212kg)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.